OM

Opaleye Management Portfolio holdings

AUM $707M
1-Year Est. Return 67.55%
This Quarter Est. Return
1 Year Est. Return
+67.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$418M
AUM Growth
+$84.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$86.9M
2
+$7.54M
3
+$6.21M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.2M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.89M

Top Sells

1
+$5.52M
2
+$4.99M
3
+$3.54M
4
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
+$3.03M
5
CYTK icon
Cytokinetics
CYTK
+$2.53M

Sector Composition

1 Healthcare 98.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$4.24M 1.01%
130,000
-77,500
27
$4.07M 0.97%
1,701,500
+865,700
28
$4.04M 0.97%
+3,370,000
29
$4.01M 0.96%
221,700
-92,300
30
$3.56M 0.85%
445,000
+387,415
31
$3.5M 0.84%
380,000
-2,400
32
$3.2M 0.76%
119,000
-68,387
33
$2.96M 0.71%
421,000
34
$2.95M 0.71%
3,074,995
+2,207,895
35
$2.54M 0.61%
305,000
+3,000
36
$1.89M 0.45%
675,000
-75,000
37
$1.82M 0.44%
220,667
-84,240
38
$1.43M 0.34%
+307,000
39
$1.39M 0.33%
+275,000
40
$1.39M 0.33%
238,225
41
$1.06M 0.25%
653,000
42
$918K 0.22%
669,944
-2,210,056
43
$759K 0.18%
+102,000
44
$595K 0.14%
275,000
+32,000
45
$586K 0.14%
+63,500
46
$474K 0.11%
+143,600
47
$242K 0.06%
9,880
-52,620
48
– –
-502,000
49
– –
-115,000
50
– –
-183,500
1
2
3